SPARC | US FDA sought new phase 3 study on cancer drug Taclantis.
10/16
United Spirits | The company initiated a strategic review of selected popular brands and the review is expected to be completed by the end of the 2021 calendar year.
11/16
SBI Cards | The company will issue NCDs worth Rs 550 crore.
12/16
Mazagon Dock | The company signed MoU with Mumbai Port Trust in Maritime India Sumit 2021.
13/16
Alkem Labs | The company received US FDA nod for generic of antibiotic drugs Omnicef and Suprax.
14/16
Aurobindo Pharma | The company has entered in binding agreements to invest Rs 5 crore in both its power plants in Hyderabad, aggregating up to over Rs 10 crore by subscribing to additional equity shares to avail the benefit of captive consumption of solar power.
15/16
REC | The company has priced $500,000,000, 2.25 percent notes due 2026, on February 22, 2021 under its USD 7 billion Global Medium Term Note Programme. The settlement date for the notes is expected to be March 1, 2021.
16/16
UPL | The company has issued an update on the fire incident at Unit 5, Jhagadia. The company issued a closure notice for the entire plant saying that operating the plant is a safety risk. The closure will take place gradually as an immediate shutdown of a chemical unit may lead to another accident.
